Better Outcomes For Your Low Vision Patients

Learn More

Sight-enhancing glasses for the visually impaired

As a healthcare provider who works with low vision patients, you have a clear understanding of the impact that visual impairment can have on their mental health, quality of life and ability to live independently.

With eSight, thousands of individuals have gained or regained access to the interests, livelihoods and Activities of Daily Living (ADLs) which allow them to enjoy full and active lives. For patients in your care, eSight may be a far more effective option than any other device, procedure, or treatment.

SHARE WITH YOUR PATIENTS

What is eSight?

eSight is a Class I Medical Device registered with the FDA and EUDAMED, and inspected by Health Canada. It displays real-time footage to the user via a high-speed, high-resolution 21.5 MP camera and projects it onto two OLED screens in front of the eyes. A handheld trackpad allows user control of color, contrast, focus, brightness and magnification, and prescription lenses can be crafted and installed directly into the unit.

eSight is currently worn by individuals managing a wide variety of common conditions, including Macular Degeneration, Diabetic Retinopathy, Ocular Albinism, Optic Atrophy, Glaucoma, and many more.

SHARE WITH YOUR PATIENTS

Many Conditions, One Solution

eSight enhances sight for the overwhelming majority of individuals living with low vision.

eSight users commonly live with:

Macular Degeneration
Stargardt's Disease
Diabetic Retinopathy
Glaucoma
Retinitis Pigmentosa (RP)
Retinal Detachment
Ocular Albinism
Cataracts
Optic Nerve Hypoplasia (ONH)
Optic Neuropathy
Optic Atrophy
Coloboma
Cone-Rode Dystrophy
Retinopathy of Prematurity (ROP)
Nystagmus
Uveitis
Leber Congenital Amaurosis
Aniridia
Checkmark icon
Macular Degeneration
Checkmark icon
Stargardt's Disease
Checkmark icon
Diabetic Retinopathy
Checkmark icon
Glaucoma
Checkmark icon
Retinitis Pigmentosa (RP)
Checkmark icon
Retinal Detachment
Checkmark icon
Ocular Albinism
Checkmark icon
Cataracts
Checkmark icon
Optic Nerve Hypoplasia (ONH)
Checkmark icon
Optic Neuropathy
Checkmark icon
Optic Atrophy
Checkmark icon
Coloboma
Checkmark icon
Cone-Rode Dystrophy
Checkmark icon
Retinopathy of Prematurity (ROP)
Checkmark icon
Nystagmus
Checkmark icon
Uveitis
Checkmark icon
Leber Congenital Amaurosis
Checkmark icon
Aniridia

Clinically Validated: The eQuest Study

A six-site clinical study entitled the “eSight Quality of Life and Efficacy Study (eQUEST)” was completed in early 2017.

The study provided validation of eSight’s efficacy for those with low vision. It showed significant improvement in multiple objective visual function measures, the ability to perform Activities of Daily Living (ADLs), and direct patient reports of eSight improving their quality of life, as measured by the well-validated “VA LV VFQ-48” questionnaire.

The eQUEST study was led by researchers from the six preeminent low vision research and rehabilitation institutions listed below.

Read the study in Optometry and Vision Science!

equest study: participants
Simple Pricing

Tell Your Patients About eSight

Interested in the potential that eSight could offer for your patients? Submit your practice information to receive more information about the eSight Clinical Consultation Program.

Clinical Consultation Program members receive:

Practice Information Form